Chemomab Therapeutics Ltd. SEC filings CMMB

Chemomab Therapeutics Ltd. has 366 filings in SEC EDGAR's recent list, going back to Nov 7, 2011. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 11, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

Chemomab Therapeutics Ltd. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 9, 2026 —
4 Insider transaction Sep 1, 2026 Aug 27, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 10, 2026 —
SCHEDULE 13D Ownership over 5% (active) Jul 16, 2026 —
3 Initial insider ownership Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Apr 10, 2026 Mar 18, 2026
3 Initial insider ownership Mar 31, 2026 Mar 18, 2026
3 Initial insider ownership Mar 31, 2026 Mar 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 23, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 10, 2025 —
SC 13D/A Amended ownership over 5% (active) Nov 29, 2024 —
SC 13G Ownership over 5% (passive) Nov 21, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 16, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
SC 13G Ownership over 5% (passive) Aug 20, 2024 —
SC 13D/A Amended ownership over 5% (active) Mar 11, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 15, 2023 —
4 Insider transaction Jul 5, 2023 Jun 14, 2023
4 Insider transaction Jun 20, 2023 Jun 16, 2023
4 Insider transaction Jun 16, 2023 Jun 14, 2023
3 Initial insider ownership Jun 5, 2023 Jun 1, 2023
4 Insider transaction Mar 23, 2023 Mar 16, 2023
4 Insider transaction Mar 23, 2023 Mar 16, 2023
4 Insider transaction Mar 23, 2023 Mar 16, 2023
4 Insider transaction Mar 23, 2023 Mar 16, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
SC 13D/A Amended ownership over 5% (active) Jan 5, 2023 —
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Nov 18, 2022 Nov 16, 2022
4 Insider transaction Nov 17, 2022 Nov 16, 2022
SC 13D/A Amended ownership over 5% (active) Nov 17, 2022 —
3 Initial insider ownership Nov 15, 2022 Nov 14, 2022
3 Initial insider ownership Jun 21, 2022 Jun 16, 2022
4 Insider transaction Jun 21, 2022 Mar 16, 2022
4 Insider transaction May 25, 2022 May 24, 2022
4 Insider transaction May 19, 2022 May 18, 2022
4 Insider transaction Mar 21, 2022 Mar 18, 2022
4 Insider transaction Mar 21, 2022 Mar 14, 2022
4 Insider transaction Mar 15, 2022 Mar 14, 2022
4 Insider transaction Mar 15, 2022 Mar 14, 2022
4 Insider transaction Mar 14, 2022 Mar 11, 2022
4 Insider transaction Mar 9, 2022 Mar 7, 2022
4 Insider transaction Mar 9, 2022 Mar 7, 2022
4 Insider transaction Mar 9, 2022 Mar 7, 2022
4 Insider transaction Mar 9, 2022 Mar 7, 2022
4 Insider transaction Mar 9, 2022 Mar 7, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2022 —
SC 13D Ownership over 5% (active) Jan 20, 2022 —
4 Insider transaction Dec 8, 2021 Dec 6, 2021
3 Initial insider ownership Nov 12, 2021 Nov 8, 2021
3 Initial insider ownership Nov 4, 2021 Oct 25, 2021
4 Insider transaction May 10, 2021 May 7, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
4 Insider transaction Apr 21, 2021 Apr 19, 2021
SC 13D/A Amended ownership over 5% (active) Apr 15, 2021 —
SC 13D Ownership over 5% (active) Mar 26, 2021 —
3 Initial insider ownership Mar 26, 2021 Mar 16, 2021
4 Insider transaction Mar 26, 2021 Mar 16, 2021
SC 13G Ownership over 5% (passive) Mar 26, 2021 —
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
3 Initial insider ownership Mar 25, 2021 Mar 16, 2021
4 Insider transaction Mar 18, 2021 Mar 16, 2021
4 Insider transaction Mar 18, 2021 Mar 16, 2021
3 Initial insider ownership Mar 18, 2021 Mar 16, 2021
4 Insider transaction Mar 12, 2021 Apr 23, 2020
3 Initial insider ownership Mar 12, 2021 Apr 23, 2020
3 Initial insider ownership Mar 11, 2021 Oct 20, 2020
4 Insider transaction Mar 11, 2021 Apr 23, 2020
3 Initial insider ownership Mar 11, 2021 Apr 23, 2020
SC 13D/A Amended ownership over 5% (active) Dec 21, 2020 —
SC 13D/A Amended ownership over 5% (active) Dec 18, 2020 —
SC 13D/A Amended ownership over 5% (active) May 22, 2020 —
3 Initial insider ownership May 7, 2020 May 1, 2020
SC 13D/A Amended ownership over 5% (active) Mar 31, 2020 —
SC 13D/A Amended ownership over 5% (active) Jan 13, 2020 —
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
3 Initial insider ownership Jan 2, 2020 Jan 1, 2020
SC 13G Ownership over 5% (passive) Jan 2, 2020 —
SC 13D/A Amended ownership over 5% (active) Dec 31, 2019 —
3 Initial insider ownership Dec 31, 2019 Jun 30, 2019
SC 13G/A Amended ownership over 5% (passive) Nov 18, 2019 —
SC 13D/A Amended ownership over 5% (active) Jun 27, 2019 —
SC 13G/A Amended ownership over 5% (passive) Jun 26, 2019 —
SC 13G Ownership over 5% (passive) Jun 11, 2019 —
SC 13D/A Amended ownership over 5% (active) Feb 25, 2019 —
SC 13D Ownership over 5% (active) Feb 21, 2019 —
SC 13D/A Amended ownership over 5% (active) Jan 8, 2013 —
SC 13D/A Amended ownership over 5% (active) Dec 17, 2012 —
SC 13D Ownership over 5% (active) Aug 16, 2012 —

Showing 124 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CMMB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Tel Aviv
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1534248
Former names
Anchiano Therapeutics Ltd. (until Mar 17, 2021); BioCancell Ltd. (until Nov 3, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.